Network meta-analysis Archives

IBD-EII Menu

Search

Filter

2021 5ASA oral, topical or combined in UC

See network meta-analysis
2021 First & second line therapy in UC

See network meta-analysis
2018 First & second line therapy in CD

See network meta-analysis
2017 Mesalamine, Sulfasalazine, Corticosteroids & Budesonide in CD

See network meta-analysis
2015 Immunosupressants & biologics in CD

See network meta-analysis
2015 Budesonide & mesalazine in CD

See network meta-analysis
2023 onset of effect biologics & small molecules UC
2023 biologics in UC
2023 Efficacy & safety of biologics & small molecules UC
2023 Efficacy of biologics & small molecules in CD

inflammatory bowel disease
This platform is intended to help share evidence-based data regarding inflammatory bowel disease in a summarized way.

Beatriz Gros
Gastroenterologist
Reina Sofía University Hospital of Córdoba (Spain)